NeuroThera Labs, a subsidiary of SciSparc Ltd., has reached a significant milestone in its FDA-approved Phase IIb clinical trial for SCI-110, a cannabinoid-based drug for treating Tourette Syndrome in adults. The company completed manufacturing and obtained batch release certification from a European Qualified Person, enabling shipment of the drug to trial sites in the US, Germany, and Israel. This progress allows patient enrollment to begin soon, marking a crucial step in evaluating SCI-110’s safety and effectiveness for a condition with limited treatment options. The trial's success could lead to new therapeutic options for Tourette Syndrome patients.
The SciSparc subsidiary NeuroThera Labs' clinical trial progress is contextually placed alongside health sector market data from Pluang as of Oct 22, 2026 19:13 WIB. Of 150 priced health-sector US stocks, 63 rose and 79 fell. Among them, ABCL trades at USD 11.98 with a 1-day change of -2.12% and a strong buy order activity of 79%, contrasting with MRVI at USD 7.40 down 2.25% and a typical hold time of 7 days, while RLAY is priced at USD 18.02 with a similar 1-day decline of -2.12% and a hold time of 12 days.
Dune Analytics has launched Dune Market Data Feeds, providing real-time trade data from over 200 onchain trading venues across 12 blockchains, including tokenized U.S. stocks from XLayer. This service enables institutional investors to track onchain ...
Lockheed Martin reported strong Q3 2026 results, beating Wall Street estimates with earnings of $7.97 per share and sales of $20.7 billion, up 11% year-over-year. Net earnings rose 14% to $1.8 billion, supported by a record backlog of $292 billion, i...
IBM reported strong Q3 results with revenue of $17.1 billion and adjusted earnings of $2.95 per share, surpassing analyst estimates. Software revenue grew 9%, led by Red Hat and OpenShift, while AI-related consulting work also contributed significant...
Cowen & Co. initiated a 'Buy' rating on CenterPoint Energy before its Q3 earnings report due October 27, 2026. Analysts expect $2.16 billion in revenue, an 8.4% increase year-over-year, and earnings of $0.50 per share, steady from last year. The comp...
Drofa Comms has released the Women Leading the Way Digital Magazine 2026, aiming to highlight women experts in finance on equal terms with men. The digital magazine features insights from 25 industry professionals and covers topics like AI in wealth ...
